These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 11984596)
1. Autoimmunity due to molecular mimicry as a cause of neurological disease. Levin MC; Lee SM; Kalume F; Morcos Y; Dohan FC; Hasty KA; Callaway JC; Zunt J; Desiderio D; Stuart JM Nat Med; 2002 May; 8(5):509-13. PubMed ID: 11984596 [TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing. Kalume F; Lee SM; Morcos Y; Callaway JC; Levin MC J Neurosci Res; 2004 Jul; 77(1):82-9. PubMed ID: 15197740 [TBL] [Abstract][Full Text] [Related]
3. HTLV-1 induced molecular mimicry in neurological disease. Lee SM; Morcos Y; Jang H; Stuart JM; Levin MC Curr Top Microbiol Immunol; 2005; 296():125-36. PubMed ID: 16323422 [TBL] [Abstract][Full Text] [Related]
4. Neuronal molecular mimicry in immune-mediated neurologic disease. Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease. Lee SM; Dunnavant FD; Jang H; Zunt J; Levin MC Neurosci Lett; 2006 Jun; 401(1-2):188-93. PubMed ID: 16600502 [TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry. Levin MC; Lee SM; Morcos Y; Brady J; Stuart J J Infect Dis; 2002 Nov; 186(10):1514-7. PubMed ID: 12404172 [TBL] [Abstract][Full Text] [Related]
7. Autoimmunity and molecular mimicry in tropical spastic paraparesis/human T-lymphotropic virus-associated myelopathy. García-Vallejo F; Domínguez MC; Tamayo O Braz J Med Biol Res; 2005 Feb; 38(2):241-50. PubMed ID: 15785836 [TBL] [Abstract][Full Text] [Related]
8. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Jernigan M; Morcos Y; Lee SM; Dohan FC; Raine C; Levin MC Neurology; 2003 Apr; 60(8):1320-7. PubMed ID: 12707436 [TBL] [Abstract][Full Text] [Related]
9. [Autoimmune syndrome in the tropical spastic paraparesis/myelopathy associated with human T-lymphotropic virus infections]. Domínguez MC; Torres M; Tamayo O; Criollo W; Quintana M; Sánchez A; García F Biomedica; 2008 Dec; 28(4):510-22. PubMed ID: 19462556 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis. Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Salapa H J Neuroimmunol; 2017 Mar; 304():56-62. PubMed ID: 27449854 [TBL] [Abstract][Full Text] [Related]
11. Post-translational glycosylation of target proteins implicate molecular mimicry in the pathogenesis of HTLV-1 associated neurological disease. Lee S; Shin Y; Marler J; Levin MC J Neuroimmunol; 2008 Nov; 204(1-2):140-8. PubMed ID: 18793806 [TBL] [Abstract][Full Text] [Related]
12. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus]. Carod-Artal FJ Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063 [TBL] [Abstract][Full Text] [Related]
13. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders. Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845 [TBL] [Abstract][Full Text] [Related]
14. Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. Yukitake M; Sueoka E; Sueoka-Aragane N; Sato A; Ohashi H; Yakushiji Y; Saito M; Osame M; Izumo S; Kuroda Y J Neurovirol; 2008 Apr; 14(2):130-5. PubMed ID: 18444084 [TBL] [Abstract][Full Text] [Related]
15. Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease. Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Groover CJ Degener Neurol Neuromuscul Dis; 2012; 2():175-187. PubMed ID: 30890887 [TBL] [Abstract][Full Text] [Related]
17. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load. de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF; J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. Yamano Y; Cohen CJ; Takenouchi N; Yao K; Tomaru U; Li HC; Reiter Y; Jacobson S J Exp Med; 2004 May; 199(10):1367-77. PubMed ID: 15136590 [TBL] [Abstract][Full Text] [Related]
19. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. Grant C; Barmak K; Alefantis T; Yao J; Jacobson S; Wigdahl B J Cell Physiol; 2002 Feb; 190(2):133-59. PubMed ID: 11807819 [TBL] [Abstract][Full Text] [Related]